Indications
Anticoagulation in adult patients with heparin-induced thrombocytopenia type II and thromboembolic disease mandating parenteral antithrombotic therapy. The diagnosis should be confirmed by the heparin-induced platelet activation assay or an equivalent test.
Composition
- Active substance
- lepirudin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Refludan
- Active substance
- lepirudin
- ATC code
- B01AE02
- Therapeutic area
- Thromboembolism, Thrombocytopenia
- Marketing authorisation holder
- Celgene Europe Ltd.
- Status